Loading...
Bleeding by Bruton Tyrosine Kinase-Inhibitors: Dependency on Drug Type and Disease
SIMPLE SUMMARY: Bruton tyrosine kinase (Btk) is expressed in B-lymphocytes, myeloid cells and platelets. Since the launch of the first in class Btk-inhibitor (BTKi) ibrutinib in 2013, the list of indications and further drug candidates has expanded greatly. BTKi are not only used to treat patients w...
Na minha lista:
| Udgivet i: | Cancers (Basel) |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7961939/ https://ncbi.nlm.nih.gov/pubmed/33806595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13051103 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|